Notice Number: NOT-OD-06-089
Release Date: August 2, 2006
National Institutes of Health (NIH), (http://www.nih.gov)
NIH announces the availability of an SBIR Niche Assessment Program for Phase I SBIR awardees in FY 2006 and FY 2007. NIH has contracted with Foresight Science and Technology to perform Technology Niche Analyses (TNA™) for 150 NIH SBIR Phase I awardees. For each eligible Phase I SBIR project, the TNA™ will assess potential uses of the technology and result in a report that includes:
1) the needs and concerns of end-users that drive the competitive opening in the market
2) competing technologies and products
3) the competitive advantage of the technology
4) who the key competitors are likely to be
5) the likely price customers will pay
6) what will drive the market
7) the key standards, regulations, and certifications influencing buyer acceptance
8) the market size and what share should be sought
9) the potential customer, licensee, investor, or other commercialization partner
10) a commercialization strategy that includes tasking and a schedule for implementation
The TNA™ process has three steps:
(1) In the first step of the analysis, Foresight will gather the pertinent information needed from the SBIR awardee to identify feasible applications of the technology. Typically several non-obvious users are found. Such secondary applications often provide a path to market that is faster than the primary biomedical use.
(2) In the second step, Foresight will analyze the selected application to determine the end-user needs, current and emerging competing technologies, market dynamics, socio-economic trends and market drivers, and to quantify the market size and participant's possible share. This second step determines the technology's current competitive advantages and how to improve competitiveness.
(3) In the third step, Foresight will recommend a market entry strategy. This strategy includes how to market the technology to end-users, how to obtain Phase III partners, and also projects revenues for the technology. Likely lead customers, testing centers, suppliers, manufacturers, and/or other relevant organizations interested in participating in the downstream research as beta testers or concurrent engineering advisors will be identified.
To validate the analyses and recommendations, Foresight will identify and qualify companies or funding agencies that might be interested in becoming commercialization partners. Follow-up communication with these potential partners will be the responsibility of the small business.
Only NIH FY 06 or FY 07 SBIR Phase I awardees are eligible to participate. For those with multiple awards, only one project per company will be accepted. Those projects that were selected for the Niche Assessment Program in previous years will not be considered for this opportunity again, however, other Phase I awards the company may have received in FY 06 or FY 07 are eligible. Note that STTR awardees are not eligible.
There are no limitations based on the type of technology being developed. For example, it is appropriate for those developing clinical products such as devices, drugs, biologics, therapeutics, and/or software, as are educational and multi-media behavioral sciences products. The program is also appropriate for those seeking strategic alliances and investors, and immediate customers.
150 slots are available and will be filled on a “first come, first served” basis. Fifty slots are available in each of the three groups below. Only one TNA ™ will be performed for each company, and you may sign up at any time for any one of the groups. It is suggested that you carefully consider your group selection in relation to when you plan to submit your Phase II application as the Technology Niche Analysis report may be helpful in the preparation of the commercialization plan that is required in an SBIR Phase II application.
Earliest Possible Start Date
Estimated Completion Date of Report
Sept 15, 2006
late Dec 2006
Dec 29, 2006
mid Apr 2007
Apr 13, 2007
late Jul 2007
The amount of time you will need to expend is minimal (perhaps only a few hours) and the cost is free. You will be expected to provide follow-up information concerning the usefulness of the report as it will be instrumental in determining the effectiveness of the program.
To participate in the program, complete the registration form available at:
http://grants.nih.gov/grants/funding/sbir_participation_form_2006.doc (MS Word format)
http://grants.nih.gov/grants/funding/sbir_participation_form_2006.pdf (PDF format)
and email or fax to Foresight at:
Ms. Jean Delmonico
Foresight Science and Technology
Telephone: 401-273-4844 X10
Questions about TNA™ may be directed to John Reimers, Director of Services at Foresight, 401-273-4844, ext. 23, email@example.com. General questions to:
Ms. Kay Etzler
NIH SBIR/STTR Program
Office of Extramural Programs
National Institutes of Health
6705 Rockledge Drive, Suite 360
Bethesda , MD 20892
Telephone: (301) 435-2713
FAX: (301) 480-0146
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)